These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Clostridioides difficile infection in US hospitals: a national inpatient sample study. Ramai D; Dang-Ho KP; Lewis C; Fields PJ; Ofosu A; Barakat M; Aamar A; Ofori E; Lai J; Lanke G; Dhaliwal A; Reddy M; Gasperino J Int J Colorectal Dis; 2020 Oct; 35(10):1929-1935. PubMed ID: 32556651 [TBL] [Abstract][Full Text] [Related]
46. Burden of Clostridium difficile infection: Associated hospitalization in a cohort of middle-aged and older adults. Chen Y; Glass K; Liu B; Korda RJ; Riley TV; Kirk MD Am J Infect Control; 2017 May; 45(5):508-511. PubMed ID: 28089675 [TBL] [Abstract][Full Text] [Related]
47. Ten-year review of Clostridium difficile infection in acute care hospitals in the USA, 2005-2014. Luo R; Barlam TF J Hosp Infect; 2018 Jan; 98(1):40-43. PubMed ID: 29017933 [TBL] [Abstract][Full Text] [Related]
48. Impact of Clostridium difficile-associated diarrhea on acute care length of stay, hospital costs, and readmission: A multicenter retrospective study of inpatients, 2009-2011. Magee G; Strauss ME; Thomas SM; Brown H; Baumer D; Broderick KC Am J Infect Control; 2015 Nov; 43(11):1148-53. PubMed ID: 26521932 [TBL] [Abstract][Full Text] [Related]
49. Epidemiological patterns and hospital characteristics associated with increased incidence of Clostridium difficile infection in Quebec, Canada, 1998-2006. Gilca R; Hubert B; Fortin E; Gaulin C; Dionne M Infect Control Hosp Epidemiol; 2010 Sep; 31(9):939-47. PubMed ID: 20677973 [TBL] [Abstract][Full Text] [Related]
51. Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review. Gabriel L; Beriot-Mathiot A J Hosp Infect; 2014 Sep; 88(1):12-21. PubMed ID: 24996516 [TBL] [Abstract][Full Text] [Related]
52. The rise in Clostridium difficile infection incidence among hospitalized adults in the United States: 2001-2010. Reveles KR; Lee GC; Boyd NK; Frei CR Am J Infect Control; 2014 Oct; 42(10):1028-32. PubMed ID: 25278388 [TBL] [Abstract][Full Text] [Related]
53. Costs Attributable to Clostridioides difficile Infection Based on the Setting of Onset. Sahrmann JM; Olsen MA; Stwalley D; Yu H; Dubberke ER Clin Infect Dis; 2023 Mar; 76(5):809-815. PubMed ID: 36285546 [TBL] [Abstract][Full Text] [Related]
54. Real-time polymerase chain reaction testing for Clostridium difficile reduces isolation time and improves patient management in a small community hospital. Catanzaro M; Cirone J Am J Infect Control; 2012 Sep; 40(7):663-6. PubMed ID: 22153847 [TBL] [Abstract][Full Text] [Related]
55. National point prevalence of Clostridium difficile in US health care facility inpatients, 2008. Jarvis WR; Schlosser J; Jarvis AA; Chinn RY Am J Infect Control; 2009 May; 37(4):263-70. PubMed ID: 19278754 [TBL] [Abstract][Full Text] [Related]
57. A prospective study of community-associated Clostridium difficile infections: the role of antibiotics and co-infections. Taori SK; Wroe A; Hardie A; Gibb AP; Poxton IR J Infect; 2014 Aug; 69(2):134-44. PubMed ID: 24780765 [TBL] [Abstract][Full Text] [Related]
58. Healthcare resource utilization for recurrent Clostridium difficile infection in a large university hospital in Houston, Texas. Aitken SL; Joseph TB; Shah DN; Lasco TM; Palmer HR; DuPont HL; Xie Y; Garey KW PLoS One; 2014; 9(7):e102848. PubMed ID: 25057871 [TBL] [Abstract][Full Text] [Related]
59. Comparative epidemiology of Clostridium difficile infection: England and the USA. King A; Mullish BH; Williams HRT; Aylin P Int J Qual Health Care; 2017 Oct; 29(6):785-791. PubMed ID: 29025123 [TBL] [Abstract][Full Text] [Related]
60. Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States. Zhang D; Prabhu VS; Marcella SW Clin Infect Dis; 2018 Apr; 66(9):1326-1332. PubMed ID: 29360950 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]